Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein.

about

Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein.

Item

http://www.wikidata.org/entity/Q35822725

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Co-expression of Interleukin-1 ...... the Circumsporozoite Protein.

@ast

Co-expression of Interleukin-1 ...... the Circumsporozoite Protein.

@en

type

Item

label

Co-expression of Interleukin-1 ...... the Circumsporozoite Protein.

@ast

Co-expression of Interleukin-1 ...... the Circumsporozoite Protein.

@en

prefLabel

Co-expression of Interleukin-1 ...... the Circumsporozoite Protein.

@ast

Co-expression of Interleukin-1 ...... the Circumsporozoite Protein.

@en

P1476

Co-expression of Interleukin-1 ...... the Circumsporozoite Protein.

@en

P2093

Alvaro Molina-Cruz

http://www.w3.org/2001/XMLSchema#string

Amy Yang

http://www.w3.org/2001/XMLSchema#string

Arnel Belmonte

http://www.w3.org/2001/XMLSchema#string

Carolina Barillas-Mury

http://www.w3.org/2001/XMLSchema#string

Dianne D Litilit

http://www.w3.org/2001/XMLSchema#string

Hong Zheng

http://www.w3.org/2001/XMLSchema#string

Liyanage P Perera

http://www.w3.org/2001/XMLSchema#string

Marcela Parra

http://www.w3.org/2001/XMLSchema#string

Phuong Thao Pham

http://www.w3.org/2001/XMLSchema#string

Sanjai Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use

CD4 T-cell subsets in malaria: TH1/TH2 revisited

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection

Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data.

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery

Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

P304

e0141141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0141141

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martha Sedegah

P577

2015-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283294202

http://www.w3.org/2001/XMLSchema#string

P698

26505634

http://www.w3.org/2001/XMLSchema#string

P921

malaria

P932

4624717

http://www.w3.org/2001/XMLSchema#string